News
Google News: Bio-Path Holdings Inc.Posted on:13 Dec 11
[PharmiWeb.com (press release)] - “Grb-2 is an important protein involved in cancer cell proliferation and survival in CML and other leukemias,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings. “BP is a novel treatment approach that uses
sorted by relevance / date